{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:57:47Z","timestamp":1783699067970,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["40225"],"award-info":[{"award-number":["40225"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12035-021-02295-z","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T09:03:53Z","timestamp":1611738233000},"page":"2792-2802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacogenetic and Association Studies on the Influence of HLA Alleles and Rivastigmine on the Iranian Patients with Late-Onset Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8504-1087","authenticated-orcid":false,"given":"Fatemeh","family":"Rezaei Rad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6319-8729","authenticated-orcid":false,"given":"Masood","family":"Ghahvechi Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5403-2628","authenticated-orcid":false,"given":"Majid","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-5425","authenticated-orcid":false,"given":"Mahdi","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"issue":"1","key":"2295_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","volume":"13","author":"A Wimo","year":"2017","unstructured":"Wimo A, Guerchet M, Ali GC, Wu YT, Prina AM, Winblad B et al (2017) The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement 13(1):1\u20137","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2295_CR2","doi-asserted-by":"publisher","first-page":"e1002272","DOI":"10.1371\/journal.pmed.1002272","volume":"14","author":"NZR Steele","year":"2017","unstructured":"Steele NZR, Carr JS, Bonham LW, Geier EG, Damotte V, Miller ZA, Desikan RS, Boehme KL, Mukherjee S, Crane PK, Kauwe JSK, Kramer JH, Miller BL, Coppola G, Hollenbach JA, Huang Y, Yokoyama JS (2017) Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: a case\u2013 control study. PLoS Med 14(3):e1002272. https:\/\/doi.org\/10.1371\/journal.pmed.1002272","journal-title":"PLoS Med"},{"issue":"4","key":"2295_CR3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.exger.2003.10.027","volume":"39","author":"G Candore","year":"2004","unstructured":"Candore G, Balistreri CR, Colonna-Romano G, Lio D, Caruso C (2004) Major histocompatibility complex and sporadic Alzheimer\u2019s disease: a critical reappraisal. Exp Gerontol 39(4):645\u2013652","journal-title":"Exp Gerontol"},{"issue":"3","key":"2295_CR4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.410300310","volume":"30","author":"WA Rocca","year":"1991","unstructured":"Rocca WA, Hofman A, Brayne C, Breteler MM, Clarke M, Copeland JR et al (1991) Frequency and distribution of Alzheimer\u2019s disease in Europe: a collaborative study of 1980\u20131990 prevalence findings. Ann Neurol 30(3):381\u2013390","journal-title":"Ann Neurol"},{"issue":"1","key":"2295_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","volume":"4","author":"YW Zhang","year":"2011","unstructured":"Zhang YW, Thompson R, Zhang H, Xu H (2011) APP processing in Alzheimer\u2019s disease. Mol Brain 4(1):3","journal-title":"Mol Brain"},{"issue":"10","key":"2295_CR6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrn2494","volume":"9","author":"L Bertram","year":"2008","unstructured":"Bertram L, Tanzi RE (2008) Thirty years of Alzheimer\u2019s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9(10):768\u2013778","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2295_CR7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000329514","volume":"1","author":"M Zamani","year":"2011","unstructured":"Zamani M, Mehri M, Kollaee A, Yenki P, Ghaffarpor M, Harirchian MH, Shahbazi M (2011) Pharmacogenetic study on the effect of Rivastigmine on PS2 and APOE genes in Iranian Alzheimer patients. Dement Geriatr Cogn Dis Extra 1(1):180\u2013189","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"5","key":"2295_CR8","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1007\/s12035-016-9890-6","volume":"54","author":"ZX Wang","year":"2017","unstructured":"Wang ZX, Wang HF, Tan L, Liu J, Wan Y, Sun FR et al (2017) Effects of HLADRB1\/DQB1 genetic variants on neuroimaging in healthy, mild cognitive impairment, and Alzheimer\u2019s disease cohorts. Mol Neurobiol 54(5):3181\u20133188","journal-title":"Mol Neurobiol"},{"issue":"5","key":"2295_CR9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ajmg.b.30899","volume":"150","author":"TL Edwards","year":"2009","unstructured":"Edwards TL, Pericak-Vance M, Gilbert JR, Haines JL, Martin ER, Ritchie MD (2009) An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Am J Med Genet B Neuropsychiatr Genet 150(5):721\u2013735","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"2","key":"2295_CR10","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1212\/NXG.0000000000000012","volume":"1","author":"M Allen","year":"2015","unstructured":"Allen M, Kachadoorian M, Carrasquillo MM, Karhade A, Manly L, Burgess JD et al (2015) Late-onset Alzheimer disease risk variants mark brain regulatory loci. Neurol Genet 1(2):e15","journal-title":"Neurol Genet"},{"issue":"7","key":"2295_CR11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/01.STR.29.7.1401","volume":"29","author":"J Chapman","year":"1998","unstructured":"Chapman J, Wang N, Treves TA, Korczyn AD, Bornstein NM (1998) ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer\u2019s dementia. Stroke 29(7):1401\u20131404","journal-title":"Stroke"},{"issue":"1","key":"2295_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-2094-9-21","volume":"9","author":"SY Chen","year":"2012","unstructured":"Chen SY, Chen TF, Lai LC, Chen JH, Sun Y, Wen LL et al (2012) Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer\u2019s disease. J Neuroinflammation 9(1):21","journal-title":"J Neuroinflammation"},{"issue":"4","key":"2295_CR13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000353395","volume":"13","author":"A Flex","year":"2014","unstructured":"Flex A, Giovannini S, Biscetti F, Liperoti R, Spalletta G, Straface G et al (2014) Effect of proinflammatory gene polymorphisms on the risk of Alzheimer\u2019s disease. Neurodegener Dis 13(4):230\u2013236","journal-title":"Neurodegener Dis"},{"issue":"6756","key":"2295_CR14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/44853","volume":"401","author":"MHC The","year":"1999","unstructured":"The MHC (1999) Complete sequence and gene map of a human major histocompatibility complex. Nature 401(6756):921","journal-title":"Nature"},{"issue":"1","key":"2295_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1742-2094-3-33","volume":"3","author":"DJ Lehmann","year":"2006","unstructured":"Lehmann DJ, Barnardo MC, Fuggle S, Quiroga I, Sutherland A, Warden DR et al (2006) Replication of the association of HLA-B7 with Alzheimer\u2019s disease: a role for homozygosity? J Neuroinflammation 3(1):33","journal-title":"J Neuroinflammation"},{"issue":"1-2","key":"2295_CR16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0531-5565(02)00161-4","volume":"38","author":"G Wick","year":"2003","unstructured":"Wick G, Berger P, Jansen-D\u00fcrr P, Grubeck-Loebenstein B (2003) A Darwinian-evolutionary concept of age-related diseases. Exp Gerontol 38(1-2):13\u201325","journal-title":"Exp Gerontol"},{"issue":"6","key":"2295_CR17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16(6):358\u2013372","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"2295_CR18","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/eji.200526000","volume":"35","author":"H Burkhardt","year":"2005","unstructured":"Burkhardt H, Sehnert B, Bockermann R, Engstr\u00f6m \u00c5, Kalden JR, Holmdahl R (2005) Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 35(5):1643\u20131652","journal-title":"Eur J Immunol"},{"issue":"9","key":"2295_CR19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF00202265","volume":"73","author":"B Fischer","year":"1995","unstructured":"Fischer B, Schmoll H, Platt D, Popa-Wagner A, Riederer P, Bauer J (1995) Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer\u2019s patients. J Mol Med 73(9):465\u2013471","journal-title":"J Mol Med"},{"issue":"1","key":"2295_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/rej.2006.9.99","volume":"9","author":"F List\u00ec","year":"2006","unstructured":"List\u00ec F, Candore G, Balistreri CR, Grimaldi MP, Orlando V, Vasto S et al (2006) Association between the HLA-A2 allele and Alzheimer disease. Rejuvenation Res 9(1):99\u2013101","journal-title":"Rejuvenation Res"},{"issue":"1","key":"2295_CR21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-510X(98)00268-8","volume":"161","author":"PS Aisen","year":"1998","unstructured":"Aisen PS, Luddy A, Durner M, Reinhard JF Jr, Pasinetti GM (1998) HLA-DR4 influences glial activity in Alzheimer\u2019s disease hippocampus. J Neurol Sci 161(1):66\u201369","journal-title":"J Neurol Sci"},{"issue":"2","key":"2295_CR22","doi-asserted-by":"crossref","first-page":"112119","DOI":"10.1017\/S0317167100049027","volume":"21","author":"MF Frecker","year":"1994","unstructured":"Frecker MF, Pryse-Philli WEM, Strong HR (1994) Immunological associations in familial and non-familial Alzheimer patients and their families. Can J Neurol Sci 21(2):112119","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"2295_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0197-4580(00)00180-9","volume":"22","author":"DJ Lehmann","year":"2001","unstructured":"Lehmann DJ, Wiebusch H, Marshall SE, Johnston C, Warden DR, Morgan K et al (2001) HLA class I, II & III genes in confirmed late-onset Alzheimer\u2019s disease. Neurobiol Aging 22(1):71\u201377","journal-title":"Neurobiol Aging"},{"issue":"5","key":"2295_CR24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00002512-199813050-00005","volume":"13","author":"CM Spencer","year":"1998","unstructured":"Spencer CM, Noble S (1998) Rivastigmine. Drugs Aging 13(5):391\u2013411","journal-title":"Drugs Aging"},{"key":"2295_CR25","doi-asserted-by":"crossref","unstructured":"Cacabelos R (2009) Pharmacogenomic biomarkers in neuropsychiatry: The path to personalized medicine in mental disorders. EuroEspes Biomedical Research Center, Institute for CNS Disorders and Genomic Medicine, Coru\u00f1a; EuroEspes Chair of Biotechnology and Genomics, Camilo Jos\u00e9 Cela University, Madrid, Spain. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes, 3 \u00a9 Springer Science + Business Media B.V\u00a0","DOI":"10.1007\/978-90-481-2298-1_1"},{"key":"2295_CR26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4939-0956-8_13","volume-title":"Pharmacogenomics in Drug Discovery and Development","author":"R Cacabelos","year":"2014","unstructured":"Cacabelos R, Cacabelos P, Torrellas C, Tellado I, Carril JC (2014) Pharmacogenomics of Alzheimer\u2019s disease: Novel therapeutic strategies for drug development. In: Pharmacogenomics in Drug Discovery and Development. Humana Press, New York, pp. 323\u2013556"},{"issue":"5","key":"2295_CR27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.comppsych.2008.02.001","volume":"49","author":"CM Braun","year":"2008","unstructured":"Braun CM, Daigneault R, Gaudelet S, Guimond A (2008) Diagnostic and Statistical Manual of Mental Disorders, symptoms of mania: which one (s) result (s) more often from right than left hemisphere lesions? Compr Psychiatry 49(5):441\u2013459","journal-title":"Compr Psychiatry"},{"issue":"3","key":"2295_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \"Mini-mental state\": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189\u2013198","journal-title":"J Psychiatr Res"},{"issue":"2","key":"2295_CR29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1096-8628(19980305)76:2<183::AID-AJMG12>3.0.CO;2-H","volume":"76","author":"M Zamani","year":"1998","unstructured":"Zamani M, Cassiman JJ (1998) Reevaluation of the importance of polymorphic HLA class II alleles and amino acids in the susceptibility of individuals of different populations to type I diabetes. Am J Med Genet 76(2):183\u2013194","journal-title":"Am J Med Genet"},{"issue":"5","key":"2295_CR30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1399-0039.1995.tb03127.x","volume":"46","author":"M Bunce","year":"1995","unstructured":"Bunce M, O\u2019neill CM, Barnardo MCNM, Krausa P, Browning MJ, Morris PJ, Welsh KI (1995) Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46(5):355\u2013367","journal-title":"Tissue Antigens"},{"key":"2295_CR31","doi-asserted-by":"crossref","unstructured":"Gholamzadeh S, Heshmati B, Mani A, Petramfar P, Baghery Z (2017) The prevalence of alzheimer\u2019s disease; its risk and protective factors among the elderly population in Iran. SEMJ 18(9)","DOI":"10.5812\/semj.57576"},{"issue":"2","key":"2295_CR32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S et al (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63(2):168\u2013174","journal-title":"Arch Gen Psychiatry"},{"issue":"5123","key":"2295_CR33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small G et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261(5123):921\u2013923","journal-title":"Science"},{"issue":"4","key":"2295_CR34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3233\/JAD-122407","volume":"36","author":"L Rasmussen","year":"2013","unstructured":"Rasmussen L, Delabio R, Horiguchi L, Mizumoto I, Terazaki CR, Mazzotti D et al (2013) Association between interleukin 6 gene haplotype and Alzheimer\u2019s disease: a Brazilian case-control study. J Alzheimers Dis 36(4):733\u2013738","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"2295_CR35","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1007\/s12035-015-9387-8","volume":"53","author":"M Zamani","year":"2016","unstructured":"Zamani M, Mohammadi M, Zamani H, Tavasoli A (2016) Pharmacogenetic Study on the Impact of Rivastigmine Concerning Genetic Variants of A2M and IL-6 Genes on Iranian Alzheimer\u2019s Patients. Mol Neurobiol 53(7):4521\u20134528","journal-title":"Mol Neurobiol"},{"issue":"5-6","key":"2295_CR36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000347128","volume":"37","author":"A Sayad","year":"2014","unstructured":"Sayad A, Noruzinia M, Zamani M, Harirchian MH, Kazemnejad A (2014) Association study of cathepsin D gene polymorphism in Iranian patients with sporadic late-onset Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 37(5-6):257\u2013264","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"2295_CR37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MAJ.0000000000000416","volume":"349","author":"L Mansouri","year":"2015","unstructured":"Mansouri L, Klai S, Gritli N, Fekih-Mrissa N, Messalmani M, Bedoui I et al (2015) Association of HLA-DR\/DQ polymorphism with Alzheimer\u2019s disease. Am J Med Sci 349(4):334\u2013337","journal-title":"Am J Med Sci"},{"issue":"5 part 2","key":"2295_CR38","first-page":"57","volume":"19","author":"D Cohen","year":"1979","unstructured":"Cohen D, Zeller E, Eisdorfer C, Walford R (1979) Alzheimer\u2019s disease and the main histocompatibility complex (HLA system). Gerontologist 19(5 part 2):57","journal-title":"Gerontologist"},{"key":"2295_CR39","first-page":"727","volume":"1","author":"RL Walford","year":"1980","unstructured":"Walford RL, Hodge SE (1980) HLA distribution in Alzheimer\u2019s disease. Histocompatibility Test 1:727\u2013729","journal-title":"Histocompatibility Test"},{"issue":"4","key":"2295_CR40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0197-4580(81)90035-X","volume":"2","author":"D Cohen","year":"1981","unstructured":"Cohen D, Eisdorfer C, Walford RL (1981) Histocompatibility antigens (HLA) and patterns of cognitive loss in dementia of the Alzheimer type. Neurobiol Aging 2(4):277\u2013280","journal-title":"Neurobiol Aging"},{"issue":"12","key":"2295_CR41","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1007\/s12272-015-0648-x","volume":"38","author":"S Shadfar","year":"2015","unstructured":"Shadfar S, Hwang CJ, Lim MS, Choi DY, Hong JT (2015) Involvement of inflammation in Alzheimer\u2019s disease pathogenesis and therapeutic potential of anti-inflammatory agents. Arch Pharm Res 38(12):2106\u20132119","journal-title":"Arch Pharm Res"},{"issue":"2-3","key":"2295_CR42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000356529","volume":"21","author":"M Serpente","year":"2014","unstructured":"Serpente M, Bonsi R, Scarpini E, Galimberti D (2014) Innate immune system and inflammation in Alzheimer\u2019s disease: from pathogenesis to treatment. Neuroimmunomodulation 21(2-3):79\u201387","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"2295_CR43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000072500","volume":"50","author":"JB Lampe","year":"2003","unstructured":"Lampe JB, Gossrau G, Herting B, Kempe A, Sommer U, F\u00fcssel M et al (2003) HLA typing and Parkinson\u2019s disease. Eur Neurol 50(2):64\u201368","journal-title":"Eur Neurol"},{"issue":"9","key":"2295_CR44","doi-asserted-by":"crossref","first-page":"11041110","DOI":"10.1002\/mds.25035","volume":"27","author":"I Ahmed","year":"2012","unstructured":"Ahmed I, Tamouza R, Delord M, Krishnamoorthy R, Tzourio C, Mulot C et al (2012) Association between Parkinson\u2019s disease and the HLA-DRB1 locus. Mov Disord 27(9):11041110","journal-title":"Mov Disord"},{"issue":"9","key":"2295_CR45","doi-asserted-by":"publisher","first-page":"e3135","DOI":"10.1371\/journal.pone.0003135","volume":"3","author":"IF Tsigelny","year":"2008","unstructured":"Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H et al (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer\u2019s and Parkinson\u2019s diseases. PLoS One 3(9):e3135. https:\/\/doi.org\/10.1371\/journal.pone.0003135","journal-title":"PLoS One"},{"issue":"1","key":"2295_CR46","doi-asserted-by":"publisher","first-page":"e86655","DOI":"10.1371\/journal.pone.0086655","volume":"9","author":"S Harjanto","year":"2014","unstructured":"Harjanto S, Ng LF, Tong JC (2014) Clustering HLA class I superfamilies using structural interaction patterns. PLoS One 9(1):e86655. https:\/\/doi.org\/10.1371\/journal.pone.0086655","journal-title":"PLoS One"},{"issue":"1","key":"2295_CR47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2008.06.018","volume":"203","author":"E Nizri","year":"2008","unstructured":"Nizri E, Irony-Tur-Sinai M, Faranesh N, Lavon I, Lavi E, Weinstock M, Brenner T (2008) Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. J Neuroimmunol 203(1):12\u201322","journal-title":"J Neuroimmunol"},{"issue":"1-2","key":"2295_CR48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(87)90696-3","volume":"79","author":"PL McGeer","year":"1987","unstructured":"McGeer PL, Itagaki S, Tago H, McGeer EG (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79(1-2):195\u2013200","journal-title":"Neurosci Lett"},{"issue":"1","key":"2295_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-015-0139-9","volume":"7","author":"DG Walker","year":"2015","unstructured":"Walker DG, Lue LF (2015) Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Alzheimers Res Ther 7(1):1\u20139","journal-title":"Alzheimers Res Ther"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02295-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02295-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02295-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T10:17:09Z","timestamp":1670926629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02295-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2295"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02295-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"19 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was certified by the ethics committee and review board of the Tehran University of Medical Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Questionnaire forms were prepared for each patient and control individuals. Before being included in the study, informed consent was taken from all the patients, or their legal guardians and control subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and Informed Consent"}},{"value":"All study participants, or their legal guardian, provided informed written consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}